Solana Company - Class A (HSDT) earnings
HSDT earnings moved a median of -2.55% by the close. Quarterly and annual HSDT reports and results, each read against the price at its own news timestamp. Back to the HSDT overview →
24 measured HSDT earnings events.
Where these HSDT earnings landedvs 23 measured HSDT earnings reactions
| Middle 50% of HSDT earnings reactions | -4.43% to -0.06% |
|---|---|
| Median reaction (to close) | -2.55% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 HSDT earnings events with a measured close landed between -4.43% and -0.06%; 22% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Solana Co For: Jun 30 | SEC filing · Form 10-Q | -1.55% | -2.35% | |
| Solana Company Reports Second Quarter 2026 Financial Results | Press release | -1.55% | -2.35% | |
| Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026 | Press release | +0.57% | -0.57% | |
| Form 10-Q Solana Co For: Mar 31 | SEC filing · Form 10-Q | +1.09% | -5.22% | |
| Solana Company Reports First Quarter 2026 Financial Results | Press release | +1.09% | -5.22% | |
| Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026 | Press release | -0.46% | -3.67% | |
| Form 10-K Solana Co For: Dec 31 | SEC filing · Form 10-K | -2.09% | -3.89% | |
| Form 10-Q Solana Co For: Sep 30 | SEC filing · Form 10-Q | -2.42% | -9.18% | |
| Solana Company Reports Third Quarter 2025 Financial Results | Press release | -2.42% | -9.18% | |
| Form NT 10-Q Solana Co For: Sep 30 | SEC filing · Form NT | -6.51% | — | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Jun 30 | SEC filing · Form 10-Q | -1.17% | +1.00% | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Mar 31 | SEC filing · Form 10-Q | -2.01% | +15.33% | |
| Form 10-K HELIUS MEDICAL TECHNOLOG For: Dec 31 | SEC filing · Form 10-K | — | -6.95% | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -0.63% | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Jun 30 | SEC filing · Form 10-Q | — | -4.43% | |
| Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results | Press release | — | -4.43% | |
| Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024 | Press release | -2.58% | -3.61% | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Mar 31 | SEC filing · Form 10-Q | -0.66% | +2.63% | |
| Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results | Press release | -0.66% | +2.63% | |
| Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 | Press release | -3.07% | +0.00% | |
| Form 10-K HELIUS MEDICAL TECHNOLOG For: Dec 31 | SEC filing · Form 10-K | +4.18% | +0.36% | |
| Form 10-Q HELIUS MEDICAL TECHNOLOG For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.55% | |
| Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results | Press release | +0.00% | -2.55% | |
| Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024 | Press release | — | -0.13% |
Keep exploring
More HSDT: analyst actions → · SEC filings → · HSDT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Puma Biotechnology Inc (PBYI) | 274 | +0.44% | 55% |
| PRANA BIOTECH (PRAN) | 274 | 0.00% | 48% |
| PRECISION OPTICS CORP NEW (PEYE) | 272 | 0.00% | 24% |
| InspireMD Inc. (NSPR) | 271 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.